{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:39:09Z","timestamp":1792132749846,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>At present, Multiplex ligation-dependent probe amplification (MLPA) and exome sequencing are common gene detection methods in patients with Duchenne muscular dystrophy or Becker muscular dystrophy (DMD\/BMD), but they can not cover the whole-genome sequence of the DMD gene. In this study, the whole genome capture of the DMD gene and next-generation sequencing (NGS) technology were used to detect the patients with DMD\/BMD in Southwest China, to clarify the application value of this technology and further study the gene variant spectrum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From 2017 to 2020, 51 unrelated patients with DMD\/BMD in southwestern China were clinically diagnosed at West China Second University Hospital of Sichuan University (Chengdu, China). The whole-genome of the DMD gene was captured from the peripheral blood of all patients, and next-generation sequencing was performed. Large copy number variants (CNVs) in the exon regions of the DMD gene were verified through MLPA, and small variations (such as single nucleotide variation and\u2009&lt;\u200950\u00a0bp fragment insertions\/deletions) were validated using Sanger sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 51 patients, 49 (96.1% [49\/51]) had pathogenic or likely pathogenic variants in the DMD gene. Among the 49 positive samples, 17 patients (34.7% [17\/49]) had CNVs in the exon regions and 32 patients (65.3% [32\/49]) had small variations. A total of six novel variants were identified: c.10916_10917del, c.1790T&gt;A, c.1842del, c.5015del, c.5791_5792insCA, and exons 38\u201350 duplication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pathogenic or likely pathogenic variants of the DMD gene were detected in 49 patients (96.1% [49\/51]), of which 6 variants (12.2% [6\/49]) had not been previously reported. This study confirmed the value of NGS-based targeted sequencing for the DMD gene expanding the spectrum of variants in DMD, which may provide effective genetic counseling and prenatal diagnosis for families.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01556-1","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:04:34Z","timestamp":1685423074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NGS-based targeted sequencing identified six novel variants in patients with Duchenne\/Becker muscular dystrophy from southwestern China"],"prefix":"10.1186","volume":"16","author":[{"given":"Feng","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/hmg\/1.1.19","volume":"1","author":"JT Dunnen","year":"1992","unstructured":"Dunnen JT, Grootscholten PM, Dauwerse JG, Walker AP, Monaco AP, Butler R, et al. Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet. 1992;1:19\u201328.","journal-title":"Hum Mol Genet"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol"},{"key":"1556_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000369343","volume":"43","author":"A Theadom","year":"2014","unstructured":"Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, et al. Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 2014;43:259\u201368.","journal-title":"Neuroepidemiology"},{"key":"1556_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mus.24880","volume":"53","author":"J Chung","year":"2016","unstructured":"Chung J, Smith AL, Hughes SC, Niizawa G, Abdel-Hamid HZ, Naylor EW, et al. Twenty-year follow-up of newborn screening for patients with muscular dystrophy. Muscle Nerve. 2016;53:570\u20138.","journal-title":"Muscle Nerve"},{"key":"1556_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00393974","volume":"35","author":"GA Danieli","year":"1977","unstructured":"Danieli GA, Mostacciuolo ML, Bonfante A, Angelini C. Duchenne muscular dystrophy. A population study. Hum Genet. 1977;35:225\u201331.","journal-title":"Hum Genet"},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00279050","volume":"54","author":"GA Danieli","year":"1980","unstructured":"Danieli GA, Mostacciuolo ML, Pilotto G, Angelini C, Bonfante A. Duchenne muscular dystrophy: data from family studies. Hum Genet. 1980;54:63\u20138.","journal-title":"Hum Genet"},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13023-019-1125-2","volume":"14","author":"K K\u00f6nig","year":"2019","unstructured":"K\u00f6nig K, Pechmann A, Thiele S, Walter MC, Schorling D, Tassoni A, et al. De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany. Orphanet J Rare Dis. 2019;14:152.","journal-title":"Orphanet J Rare Dis"},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.pcl.2015.03.008","volume":"62","author":"N Wein","year":"2015","unstructured":"Wein N, Alfano L, Flanigan KM. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am. 2015;62:723\u201342.","journal-title":"Pediatr Clin North Am"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00246-018-1881-0","volume":"39","author":"TD da Silva","year":"2018","unstructured":"da Silva TD, Massetti T, Crocetta TB, de Mello Monteiro CB, Carll A, Vanderlei LCM, et al. Heart rate variability and cardiopulmonary dysfunction in patients with Duchenne muscular dystrophy: a systematic review. Pediatr Cardiol. 2018;39:869\u201383.","journal-title":"Pediatr Cardiol"},{"key":"1556_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2003;2:731\u201340.","journal-title":"Lancet Neurol"},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2350-13-73","volume":"13","author":"S Brioschi","year":"2012","unstructured":"Brioschi S, Gualandi F, Scotton C, Armaroli A, Bovolenta M, Falzarano MS, et al. Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype. BMC Med Genet. 2012;13:73.","journal-title":"BMC Med Genet"},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","volume":"28","author":"M Ishizaki","year":"2018","unstructured":"Ishizaki M, Kobayashi M, Adachi K, Matsumura T, Kimura E. Female dystrophinopathy: review of current literature. Neuromuscul Disord. 2018;28:572\u201381.","journal-title":"Neuromuscul Disord"},{"key":"1556_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/mus.27041","volume":"62","author":"F Barthelemy","year":"2020","unstructured":"Barthelemy F, Woods JD, Nieves-Rodriguez S, Douine ED, Wang R, Wanagat J, et al. A well-tolerated core needle muscle biopsy process suitable for children and adults. Muscle Nerve. 2020;62:688\u201398.","journal-title":"Muscle Nerve"},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/jhg.2016.7","volume":"61","author":"M Okubo","year":"2016","unstructured":"Okubo M, Minami N, Goto K, Goto Y, Noguchi S, Mitsuhashi S, et al. Genetic diagnosis of Duchenne\/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutations. J Hum Genet. 2016;61:483\u20139.","journal-title":"J Hum Genet"},{"issue":"10","key":"1556_CR16","first-page":"1910","volume":"11","author":"FDE De Palma","year":"2021","unstructured":"De Palma FDE, Nunziato M, D\u2019Argenio V, Savarese M, Esposito G, Salvatore F. Comprehensive molecular analysis of DMD gene increases the diagnostic value of dystrophinopathies: a pilot study in a Southern Italy cohort of patients. Diagnostics (Basel, Switzerland). 2021;11(10):1910.","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/jhg.2010.49","volume":"55","author":"Y Takeshima","year":"2010","unstructured":"Takeshima Y, Yagi M, Okizuka Y, Awano H, Zhang Z, Yamauchi Y, et al. Mutation spectrum of the dystrophin gene in 442 Duchenne\/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet. 2010;55:379\u201388.","journal-title":"J Hum Genet"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mus.25396","volume":"55","author":"A Cho","year":"2017","unstructured":"Cho A, Seong MW, Lim BC, Lee HJ, Byeon JH, Kim SS, et al. Consecutive analysis of mutation spectrum in the dystrophin gene of 507 Korean boys with Duchenne\/Becker muscular dystrophy in a single center. Muscle Nerve. 2017;55:727\u201334.","journal-title":"Muscle Nerve"},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/jhg.2014.54","volume":"59","author":"R Santos","year":"2014","unstructured":"Santos R, Gon\u00e7alves A, Oliveira J, Vieira E, Vieira JP, Evangelista T, et al. New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy. J Hum Genet. 2014;59:454\u201364.","journal-title":"J Hum Genet"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-014-0220-7","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Zhao L, Zhou S, Hu C, Shi Y, Shi W, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0\u201318 years old) in East China. Orphanet J Rare Dis. 2015;10:5.","journal-title":"Orphanet J Rare Dis"},{"key":"1556_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.572006","volume":"11","author":"YR Tong","year":"2020","unstructured":"Tong YR, Geng C, Guan YZ, Zhao YH, Ren HT, Yao FX, et al. A comprehensive analysis of 2013 dystrophinopathies in China: a report from National Rare Disease Center. Front Neurol. 2020;11: 572006.","journal-title":"Front Neurol"},{"key":"1556_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/jhg.2015.43","volume":"60","author":"R Guo","year":"2015","unstructured":"Guo R, Zhu G, Zhu H, Ma R, Peng Y, Liang D, et al. DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. J Hum Genet. 2015;60:435\u201342.","journal-title":"J Hum Genet"},{"key":"1556_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00205170","volume":"86","author":"AH Beggs","year":"1990","unstructured":"Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD\/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45\u20138.","journal-title":"Hum Genet"},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1055\/s-0034-1383824","volume":"45","author":"H Trippe","year":"2014","unstructured":"Trippe H, Wieczorek S, K\u00f6tting J, Kress W, Schara U. Xp21\/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy. Neuropediatrics. 2014;45:333\u20135.","journal-title":"Neuropediatrics"},{"key":"1556_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00303-5","author":"P Labisa","year":"2021","unstructured":"Labisa P, Andreozzi V, Mota M, Monteiro S, Alves R, Almeida J, et al. Cost of Illness in patients with Duchenne muscular dystrophy in Portugal: the COIDUCH study. Pharmacoecon Open. 2021. https:\/\/doi.org\/10.1007\/s41669-021-00303-5.","journal-title":"Pharmacoecon Open"},{"key":"1556_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0317167100011896","volume":"38","author":"JK Mah","year":"2011","unstructured":"Mah JK, Selby K, Campbell C, Nadeau A, Tarnopolsky M, McCormick A, et al. A population-based study of dystrophin mutations in Canada. Can J Neurol Sci. 2011;38:465\u201374.","journal-title":"Can J Neurol Sci"},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/humu.22390","volume":"34","author":"CL Bladen","year":"2013","unstructured":"Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, et al. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat. 2013;34:1449\u201357.","journal-title":"Hum Mutat"},{"key":"1556_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007;447:87\u201391.","journal-title":"Nature"},{"key":"1556_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/nat.2013.0451","volume":"24","author":"Y Echigoya","year":"2014","unstructured":"Echigoya Y, Yokota T. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides. Nucleic Acid Ther. 2014;24:57\u201368.","journal-title":"Nucleic Acid Ther"},{"key":"1556_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jpm8040038","volume":"8","author":"KRQ Lim","year":"2018","unstructured":"Lim KRQ, Yoon C, Yokota T. Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy. J Pers Med. 2018;8:38.","journal-title":"J Pers Med"},{"key":"1556_CR31","doi-asserted-by":"publisher","first-page":"eeay6812","DOI":"10.1126\/sciadv.aay6812","volume":"6","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li H, Min YL, Sanchez-Ortiz E, Huang J, Mireault AA, et al. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Sci Adv. 2020;6:eeay6812.","journal-title":"Sci Adv"},{"key":"1556_CR32","doi-asserted-by":"publisher","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","volume":"5","author":"YL Min","year":"2019","unstructured":"Min YL, Li H, Rodriguez-Caycedo C, Mireault AA, Huang J, Shelton JM, et al. CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci Adv. 2019;5:eaav4324.","journal-title":"Sci Adv"},{"key":"1556_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12881-019-0912-x","volume":"20","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ma D, Liu G, Wang Y, Liu A, Li L, et al. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center. BMC Med Genet. 2019;20:180.","journal-title":"BMC Med Genet"},{"key":"1556_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-018-0853-z","volume":"13","author":"P Ma","year":"2018","unstructured":"Ma P, Zhang S, Zhang H, Fang S, Dong Y, Zhang Y, et al. Comprehensive genetic characteristics of dystrophinopathies in China. Orphanet J Rare Dis. 2018;13:109.","journal-title":"Orphanet J Rare Dis"},{"key":"1556_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cca.2015.07.002","volume":"448","author":"F Roucher Boulez","year":"2015","unstructured":"Roucher Boulez F, Menassa R, Streichenberger N, Manel V, Mallet-Motak D, Morel Y, et al. A splicing mutation in the DMD gene detected by next-generation sequencing and confirmed by mRNA and protein analysis. Clin Chim Acta. 2015;448:146\u20139.","journal-title":"Clin Chim Acta"},{"key":"1556_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1399-0004.2009.01173.x","volume":"75","author":"AT Helderman-van den Enden","year":"2009","unstructured":"Helderman-van den Enden AT, de Jong R, den Dunnen JT, Houwing-Duistermaat JJ, Kneppers AL, Ginjaar HB, et al. Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet. 2009;75:465\u201372.","journal-title":"Clin Genet"},{"issue":"3","key":"1556_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000472193","volume":"4","author":"AM Barbieri","year":"1996","unstructured":"Barbieri AM, Soriani N, Ferlini A, Michelato A, Ferrari M, Carrera P. Seven novel additional small mutations and a new alternative splicing in the human dystrophin gene detected by heteroduplex analysis and restricted RT-PCR heteroduplex analysis of illegitimate transcripts. Eur J Hum Genet. 1996;4(3):183\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1556_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/374176","volume":"72","author":"KM Flanigan","year":"2003","unstructured":"Flanigan KM, von Niederhausern A, Dunn DM, Alder J, Mendell JR, Weiss RB. Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet. 2003;72(4):931\u20139.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1556_CR39","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/humu.21114","volume":"30","author":"KM Flanigan","year":"2009","unstructured":"Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, et al. United Dystrophinopathy Project Consortium; Weiss RB. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat. 2009;30(12):1657\u201366.","journal-title":"Hum Mutat"},{"key":"1556_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fgene.2020.00131","volume":"11","author":"M Neri","year":"2020","unstructured":"Neri M, Rossi R, Trabanelli C, Mauro A, Selvatici R, Falzarano MS, et al. The genetic landscape of dystrophin mutations in Italy: a nationwide study. Front Genet. 2020;11:131.","journal-title":"Front Genet."},{"issue":"4","key":"1556_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.57.4.645","volume":"57","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Buzin CH, Feng J, Yan J, Serrano C, Sangani DS, et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology. 2001;57(4):645\u201350.","journal-title":"Neurology."},{"key":"1556_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2156-2-17","volume":"2","author":"RR Bennett","year":"2001","unstructured":"Bennett RR, den Dunnen J, O'Brien KF, Darras BT, Kunkel LM. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet. 2001;2:17.","journal-title":"BMC Genet."},{"issue":"1","key":"1556_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.10283","volume":"23","author":"RM Hofstra","year":"2004","unstructured":"Hofstra RM, Mulder IM, Vossen R, de Koning-Gans PA, Kraak M, Ginjaar IB,  et al. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat. 2004;23(1):57\u201366.","journal-title":"Hum Mutat."},{"issue":"10","key":"1556_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.nmd.2004.05.002","volume":"14","author":"S Tuffery-Giraud","year":"2004","unstructured":"Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, et al. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord. 2004;14(10):650\u20138.","journal-title":"Neuromuscul Disord."},{"issue":"1","key":"1556_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.1380040102","volume":"4","author":"RG Roberts","year":"1994","unstructured":"Roberts RG, Gardner RJ, Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat. 1994;4(1):1\u201311.","journal-title":"Hum Mutat."},{"issue":"1","key":"1556_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21290","volume":"63","author":"OL Gurvich","year":"2008","unstructured":"Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB, et al. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol. 2008;63(1):81\u20139.","journal-title":"Ann Neurol."},{"issue":"9","key":"1556_CR47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0960-8966(02)00069-X","volume":"12","author":"LC Dolinsky","year":"2002","unstructured":"Dolinsky LC, de Moura-Neto RS, Falc\u00e3o-Concei\u00e7\u00e3o DN. DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene. Neuromuscul Disord. 2002;12(9):845\u20138.","journal-title":"Neuromuscul Disord."},{"issue":"8\u20139","key":"1556_CR48","first-page":"775","volume":"159","author":"G Lesca","year":"2003","unstructured":"Lesca G, Demarquay G, Llense S, Streichenberger N, Petiot P, Michel-Calemard L, et al. Les conductrices symptomatiques pour les dystrophinopathies avec biais d'inactivation du chromosome X [Symptomatic carriers of dystrophinopathy with chromosome X inactivation bias]. Rev Neurol (Paris). 2003;159(8\u20139):775-80. French.","journal-title":"Rev Neurol (Paris)."},{"issue":"7","key":"1556_CR49","doi-asserted-by":"publisher","first-page":"e22445","DOI":"10.1002\/jcla.22445","volume":"32","author":"Y Xu","year":"2018","unstructured":"Xu Y, Li Y, Song T, Guo F, Zheng J, Xu H, et al. A retrospective analysis of 237 Chinese families with Duchenne muscular dystrophy history and strategies of prenatal diagnosis. J Clin Lab Anal. 2018;32(7):e22445.","journal-title":"J Clin Lab Anal."},{"issue":"1","key":"1556_CR50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajmg.1320570107","volume":"57","author":"TW Prior","year":"1995","unstructured":"Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, et al. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet. 1995;57(1):22\u201333.","journal-title":"Am J Hum Genet."},{"issue":"3","key":"1556_CR51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s004390050702","volume":"102","author":"S Tuffery","year":"1998","unstructured":"Tuffery S, Chambert S, Bareil C, Sarda P, Coubes C, Echenne B, et al. Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: from Southern blot to protein truncation test. Hum Genet. 1998;102(3):334\u201342.","journal-title":"Hum Genet."},{"issue":"9","key":"1556_CR52","doi-asserted-by":"publisher","first-page":"e108038","DOI":"10.1371\/journal.pone.0108038","volume":"9","author":"C Chen","year":"2014","unstructured":"Chen C, Ma H, Zhang F, Chen L, Xing X, Wang S,  et al. Screening of Duchenne muscular dystrophy (DMD) mutations and investigating its mutational mechanism in Chinese patients. PLoS One. 2014;9(9):e108038.","journal-title":"PLoS One."},{"issue":"17","key":"1556_CR53","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/elps.201300207","volume":"34","author":"CA Chen","year":"2013","unstructured":"Chen CA, Chang MY, Chang TM, Jong YJ, Wu SM. Capillary electrophoresis for analysis of deletion and duplication in exon 44-55 of Duchenne muscular dystrophy gene. Electrophoresis. 2013;34(17):2503\u201310.","journal-title":"Electrophoresis."},{"issue":"3","key":"1556_CR54","first-page":"81","volume":"47","author":"I Hrdlicka","year":"2001","unstructured":"Hrdlicka I, Zadina J, Krejc\u00ed R, Srbov\u00e1 A, Kucerov\u00e1 M. Patterns of deletions and the distribution of breakpoints in the dystrophin gene in Czech patients with Duchenne and Becker muscular dystrophy (statistical comparison with results from several other countries). Folia Biol (Praha). 2001;47(3):81\u20137.","journal-title":"Folia Biol (Praha)."},{"issue":"2","key":"1556_CR55","first-page":"140","volume":"13","author":"JG Zimowski","year":"2009","unstructured":"Zimowski JG, Holding M, Fidzia\u0144ska E, Fidzia\u0144ska A, Ryniewicz B, Dobosz I, et al. Wykrywanie rzadkich mutacji w genie dystrofiny [Detection of rare mutations in the dystrophin gene]. Med Wieku Rozwoj. 2009;13(2):140\u20135. Polish.","journal-title":"Med Wieku Rozwoj."},{"issue":"1","key":"1556_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y","volume":"80","author":"MP Moizard","year":"1998","unstructured":"Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998;80(1):32\u201341.","journal-title":"Am J Med Genet."},{"issue":"5","key":"1556_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1399-0004.1996.tb02383.x","volume":"50","author":"S Sinha","year":"1996","unstructured":"Sinha S, Mishra S, Singh V, Mittal RD, Mittal B. High frequency of new mutations in North Indian Duchenne\/Becker muscular dystrophy patients. Clin Genet. 1996;50(5):327\u201331.","journal-title":"Clin Genet."},{"issue":"4","key":"1556_CR58","first-page":"682","volume":"46","author":"XY Hu","year":"1990","unstructured":"Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet. 1990;46(4):682\u201395.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"1556_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10048-004-0204-1","volume":"6","author":"B Janssen","year":"2005","unstructured":"Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics. 2005;6(1):29\u201335.","journal-title":"Neurogenetics."},{"issue":"11","key":"1556_CR60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/sj.ejhg.5201465","volume":"13","author":"T Lalic","year":"2005","unstructured":"Lalic T, Vossen RH, Coffa J, Schouten JP, Guc-Scekic M, Radivojevic D, Djurisic M, Breuning MH, White SJ, den Dunnen JT. Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet. 2005;13(11):1231\u20134.","journal-title":"Eur J Hum Genet."},{"issue":"1","key":"1556_CR61","first-page":"54","volume":"49","author":"AH Beggs","year":"1991","unstructured":"Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet. 1991;49(1):54\u201367.","journal-title":"Am J Hum Genet."}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01556-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01556-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01556-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:11:46Z","timestamp":1685423506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01556-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01556-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2591411\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of West China Second University Hospital of Sichuan University (medical research 2016-2-8) and all experiments were performed in accordance with relevant guidelines and regulations. All patients and guardians received genetic counseling and provided written informed consent as dictated by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}